Assignee
REITER ROBERT E
US·5 granted patents·2 pending applications·5 citations·filing 2008–2011
Top patents by PatentIndex Score
7 records- 0178US8759006B2PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasiaREITER ROBERT E·Filed 2008·Granted Jun 24, 2014·1 cites·5 claims
- 0277US8703920B2Fully human antibodies against N-cadherinREITER ROBERT E·Filed 2009·Granted Apr 22, 2014·2 cites·3 claims
- 0377US8663635B2N-cadherin: target for cancer diagnosis and therapyREITER ROBERT E·Filed 2008·Granted Mar 4, 2014·2 cites·10 claims
- 0463US8524460B2PSCA: prostate stem cell antigen and uses thereofREITER ROBERT E·Filed 2011·Granted Sep 3, 2013·0 cites·17 claims
- 0558US9388247B2Antibodies against cancer target block tumor growth, angiogenesis and metastatisREITER ROBERT E·Filed 2009·Granted Jul 12, 2016·0 cites·13 claims
- 0643US2013274128A1Gene expression in n-cadherin overexpressing prostate cancers and their controlsREITER ROBERT E·Filed 2011·Application pending·0 cites
- 0742US2013137584A1Novel diagnostic and therapeutic targets associated with or regulated by n-cadherin expression and/or epithelial to mesenchymal transition (emt) in prostate cancer and other malignanciesREITER ROBERT E·Filed 2011·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →